Druggio Logo

Druggio

Ono Pharmaceutical

Ono Pharmaceutical is a Japanese pharmaceutical company that was founded in 1717. The company focuses on the research and development of innovative pharmaceutical products in the fields of oncology, immunology, neurology, and metabolic diseases. They have developed drugs for the treatment of cancer, multiple sclerosis, rheumatoid arthritis, and diabetes among other conditions. Ono Pharmaceutical is known for its commitment to advancing medical science and improving patient outcomes.

Ono Pharmaceutical's Drugs

Adlumiz

Approval date

2021/1/22

Ongentys

Approval date

2020/6/29

Velexbru

Approval date

2020/3/25

Coralan

Approval date

2019/9/20

Mektovi

Approval date

2019/1/8

Demser

Approval date

2019/1/8

Braftovi

Approval date

2019/1/8

Parsabiv

Approval date

2016/12/19

Kyprolis

Approval date

2016/7/4

Opdivo

Approval date

2014/7/4

Proemend

Approval date

2011/9/26

Exelon

Approval date

2011/4/22

Emend

Approval date

2009/10/16

Recalbon, Bonoteo

Approval date

2009/1/21

Treats

Osteoporosis
Uritos, Staybla

Approval date

2007/4/18

Onoact

Approval date

2002/7/5

Elaspol

Approval date

2002/4/11